Bromoethylamine is a reactive haloamine intermediate used in pharmaceutical synthesis, including as a building block for certain beta-adrenergic-related compounds, and tracked as a potential genotoxic impurity in relevant manufacturing routes. Simson Pharma's Bromoethylamine reference standard supports genotoxic-impurity control in API production.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bromoethylamine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.